Plain-English translation of NCT07109440 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new imaging scan called FAPI PET/CT that may help doctors better understand colorectal cancer that has spread to the liver. The scan works by targeting specific cells called cancer-associated fibroblasts that live within tumors. Researchers hope this imaging approach will help them see how the cancer is growing and predict how well treatment will work before surgery.
When colorectal cancer spreads to the liver, doctors need better ways to understand how the cancer is growing and how it interacts with healthy liver tissue. This information could help predict which patients will do well with surgery and identify those who might benefit from different treatment approaches.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive the new FAPI PET/CT imaging scan before your scheduled liver surgery. The scan is a type of medical imaging test that takes pictures of your liver to help doctors understand the cancer's behavior. You may have this scan either before or after receiving chemotherapy, depending on your treatment plan.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Belgium
Sponsor
Jules Bordet Institute
Enrollment target
~50 participants
Started
May 2025
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Loubna Taraji, MS
Jules Bordet Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.